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Background: Streptococcus bovis bacteremia has been associated with gastrointesti-
nal diseases, especially colon cancer, neoplastic colon polyps, and other malignancies 
of the GI tract in adults. Sporadic cases of S. bovis disease have also been reported in 
neonates and young infants. Although uncommon, S. bovis infection can cause fulmi-
nant neonatal sepsis and meningitis.
Objectives: We report a series of pediatric patients with S. bovis bacteremia in a county 
hospital in a United States–Mexico border city in order to examine the demographic and 
clinical associations.
Methods: We characterized the demographic and clinical features in all pediatric patients 
with blood cultures positive for S. bovis at University Medical Center in El Paso, TX, 
USA between January 2000 and December 2010. Hospital records were systematically 
reviewed by using a standardized protocol.
results: A total of seven episodes of S. bovis bacteremia were documented in seven 
pediatric patients (four female and three male). Mean age was 1.2 days (range 1–3 days), all 
were Hispanic, average birth weight (3.25 kg). Mode of delivery was spontaneous vaginal 
delivery (five) and Caesarian section (two). All of our patients developed early (<1 week) onset 
disease and presented with signs of respiratory distress. Five out of seven babies presented 
with abdominal distention and diarrhea. Six had clinical evidence of sepsis at presentation. 
Respiratory distress was the most common manifestation of sepsis (seven). Aspiration 
pneumonia was diagnosed in two of them. Most patients were treated with a combination 
of antibiotics (six), either ampicillin and gentamicin or ampicillin and cefotaxime, and one with 
ampicillin alone. None of the pediatric patients had endoscopy and none of them died.
conclusion: Streptococcus bovis is considered as an uncommon pathogen in the new-
born, but can be associated with substantial morbidity and mortality if not identified and 
treated early. Physicians should be alert to the less common presentation of neonatal 
bacteremia due to S. bovis.
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inTrODUcTiOn
Streptococcus bovis is a non-enterococcal streptococcus in the 
Lancefield group D that may be found as a normal inhabitant of 
the human gastrointestinal tract in up to 16% of the population. 
The association between S. bovis bacteremia with endocarditis 
and gastrointestinal diseases, especially colon cancer, neoplastic 
colon polyps, and other gastrointestinal malignancies in adults 
has been well established in the literature (1–7). A meta-analysis 
reported that patients with positive S. bovis infection had higher 
concomitant rates of adenomas (43%) and colon carcinomas 
(18%) compared with the general asymptomatic population (8). 
Fernandez-Ruiz et  al. reported that adenomatous polyps were 
found in 21/59 patients (36%) and was the most common finding 
among all abnormal colonic pathology results (9).
Several cases of S. bovis bacteremia have been reported in 
neonates and young infants (10–14). The clinical conditions that 
predispose to S. bovis infection in this population are unclear 
(15). The purpose of this study was to review the presentation 
of S. bovis bacteremia in pediatric patients. We report the demo-
graphic and clinical features of pediatric patients with S. bovis 
bacteremia in a United States–Mexico border city.
MaTerials anD MeThODs
Between January 2000 and December 2010, all blood cultures 
positive for S. bovis submitted to the Bacteriologic Reference 
Laboratory of Texas Tech University Health Science Center, El 
Paso, TX, USA were identified.
After the approval of the protocol by the Institutional Review 
Board of Texas Tech University Health Science Center, the 
patient’s clinical records were systematically reviewed. Using 
a standardized protocol, we characterized their birth records, 
infant’s gestational age, birth weight, sex, and age at presentation. 
Maternal age, antenatal problems, and problems during labor 
were also identified from infant’s birth records.
The Texas Public Use Data File (PUDF) was used to estimate 
the total number of deliveries that occurred at the county hospital 
during the 11-year study period (January 2000 through December 
2010). ICD-9-CM code V27 was used to identify deliveries. 
PUDF data covering the years 2004 through 2007 were readily 
available to the authors and were used to extrapolate the number 
of deliveries to the study period. The number of cases of S. bovis 
bacteremia was divided by the estimated number of deliveries at 
our county hospital.
Concomitant clinical variables were explored. Descriptive 
statistics of clinical characteristics were conducted by using the 
means, average, and percentages of data collected. Continuous 
variables were described using mean and SD, whereas categorical 
variables were described using frequencies and percentages.
resUlTs
A total of seven pediatric patients were diagnosed with S. bovis 
bacteremia during the study period. The estimated number of 
deliveries at the county hospital during the study period was 
54,714 and 98% of the babies delivered at UMC were Hispanic, 
resulting in an unadjusted incidence of S. bovis bacteremia of 
7/54,714 or 1.3 cases/10,000 births. The proportion of all bactere-
mias in neonates during that time period due to S. bovis was 7/756 
(0.93%). If we remove blood cultures positive for Staphylococcus 
epidermidis, a probable contaminant, the clinically relevant pro-
portion would be 7/433 (1.62%).
The neonates with S. bovis bacteremia included four (57%) 
female and three (42%) male, mean age of 1.2  days (range 
1–3 days), and all were Hispanic. The clinical features of these 
babies with S. bovis bacteremia are summarized in Table 1. The 
mothers’ ages ranged from 17 to 33 years. One mother had a prior 
history of hydrops fetalis. All other obstetrical histories from 
previous pregnancies were normal. Maternal diagnosis during 
pregnancy, labor, and delivery included chorioamnionitis (two), 
oligohydramnios (two), and meconium stained fluid (five). Two 
had two of these complications. Review of labor and deliveries 
revealed the following: mode of delivery was spontaneous vaginal 
delivery (SVD) in five (71%) and caesarian section in two (28%). 
Six were uncomplicated and one SVD, which had be converted 
into vacuum assisted. Mean gestational age was 39 weeks (range 
38–42); average birth weight was (3.25 kg).
Five out of seven babies presented with abdominal disten-
tion and diarrhea. Respiratory distress was present in all babies; 
all of them had evidence of meconium in the airway based on 
endotracheal intubation done at birth. Aspiration pneumonia 
secondary to meconium aspiration was diagnosed in two of them. 
Clinical evidence of sepsis was present in most of them 6 (75%). 
All patients except one were treated with combination antibiotics 
(six), either parenteral ampicillin and gentamicin or ampicillin 
and cefotaxime. One patient was treated with ampicillin alone. 
Duration of antibiotic therapy varied from 7 to 21 days (mean 
12  days). Endoscopic evaluation was not performed in any of 
them since it was not clinically indicated. No other complications 
were noticed at the time of discharge. None of the patients died, 
but subsequent follow-up was not performed as it was beyond the 
scope of this study.
DiscUssiOn
In our study of S. bovis bacteremia in predominantly Hispanic 
neonatal patients in a county hospital setting, we found that 
S. bovis is an uncommon pathogen in the newborn that should be 
identified and treated early to avoid possible substantial morbid-
ity and mortality.
Several cases of S. bovis bacteremia have previously been 
reported in neonates and young infants (14–16). S. bovis is 
considered as an uncommon pathogen in the newborn. This 
uncommon infection appears to be associated with substantial 
morbidity and mortality (17). The pathogenesis or clinical condi-
tions that predispose to S. bovis infection in this population is 
unclear. It has been suggested that early-onset (up to 1 week) of S. 
bovis infection might result from transmission of bacteria either 
intrapartum or during passage through a colonized birth canal 
and late-onset disease may occur as a consequence of postnatal 
acquisition of the organism (15).
Different microbiological classification of S. bovis subspecies 
may have various relationships to colorectal neoplasia in adults 
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(8, 18, 19). Patients infected with S. gallolyticus subsp gallolyticus 
(biotype I) were noted to have an increased rate of colorectal 
neoplasia and infective endocarditis (8). In contrast to the S. bovis 
biotype I, S. bovis biotype II caused more biliary tract infections 
and acute cholecystitis than biotype I (18, 19). It would be inter-
esting to known if biotype I was involved in this study but our 
laboratory did not perform genotype testing.
Since the 1970s, several large series in adults with S. bovis 
bacteremia and its association with colorectal neoplasia has been 
reported (1, 3, 16, 20). There have been five case series that included 
both adult and pediatric patients with S. bovis bacteremia (10–14). 
In these previous reported studies, there were 137 adults and only 
16 pediatric cases. Other researchers also noted the association 
of S. bovis bacteremia with extra-colonic malignancies, includ-
ing carcinoma of the esophagus, squamous cell carcinoma of the 
mouth, adenocarcinoma of the stomach, endometrial cancer, 
Kaposi sarcoma pancreatic cancer, and gastric lymphoma (11, 
18–22). However, these complications have not been reported in 
children and were not present in our cohort (11, 21–25).
It seems that S. bovis bacteremia has different implications in 
adults and in children. The hypotheses of disease pathophysiol-
ogy are probably different, as well as the variables of interest. In 
our series of predominantly Hispanic patients, seven infants were 
found to have S. bovis bacteremia. Contrary to what was described 
by Gerber et  al. (15), all of our patients developed early-onset 
(<1 week) disease and presented with signs of respiratory distress, 
which included cyanosis, tachypnea, and apnea attacks. In their 
case series, most infants presented with gastrointestinal illness 
with late-onset of disease (>1  week). Five out of seven babies 







sex Birth  
weight (kg)




1 1 40 M 3.09 SVD-vacuum assisted Meconium stained amniotic fluid Ampicillin – 14
Respiratory distress Gentamicin – 7
Aspiration pneumonia
2 1 41 M 4.03 SVD Maternal oligohydramnios Ampicillin – 10




3 1 39 F 3.25 SVD Maternal chorioamnionitis Ampicillin – 10
Maternal fever in labor Gentamicin – 10
Neonatal sepsis
4 1 40 F 4.06 Caesarian section Meconium stained amniotic fluid Ampicillin – 10
Respiratory distress
Sepsis
5 3 38 M 3.59 SVD Fever Ampicillin – 21
Meningitis Gentamicin – 21
Sepsis
6 1 42 F 3.31 SVD Maternal chorioamnionitis Ampicillin – 7
Meconium stained amniotic fluid Gentamicin – 7
Sepsis
7 1 39 F 2.40 Caesarian section Meconium stained amniotic fluid Ampicillin – 10
Respiratory distress Gentamicin – 1
Sepsis
SVD, spontaneous vaginal delivery.
presented with abdominal distention and diarrhea in our series. 
In both series, it remains uncertain how these babies acquired the 
infection, but it is possible that early-onset S. bovis infection might 
result from transmission of bacteria either intrapartum or during 
passage through a colonized birth canal. It has been speculated 
that gut ischemia from anoxia can compromise the intestinal 
mucosa allowing translocation of previously commensal bacteria 
with subsequent systemic dissemination. However, in neonates, 
respiratory distress is a major sign of neonatal sepsis. Our entire 
cohort presented with respiratory distress soon after birth, which 
we could hypothesize to be a sign of an early infection with S. bovis, 
but there was also evidence of meconium in their airway which can 
also cause respiratory distress in this age group. Another important 
finding is the presence of meconium stained deliveries as we can 
speculate the presence of neonatal distress secondary to an early 
S. bovis infection. Late-onset disease may occur as a consequence 
of postnatal acquisition of the organism (15). It is possible that S. 
bovis may have colonized the meconium (with or without prema-
ture rupture of membrane). No other bacteria were reported to 
grow in blood culture (to support a mixed infection as a cause).
All except one of the babies in our study were treated with 
combination antibiotics. One was treated with ampicillin alone. 
All babies received antibiotics for 7–21 days. The response time 
was not clearly documented. So, we cannot determine how quickly 
the neonates responded to antibiotic therapy. The most common 
choice was ampicillin and gentamicin as is the standard of care 
in the neonatal intensive care unit to treat patients with respira-
tory distress and suspected sepsis. As reported in a prospective 
study by Corredoira et al., beta-lactam group of antibiotics are 
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a reasonable first line treatment of S. bovis infection given that 
in their study there was no penicillin resistance among S. bovis 
isolates (26).
Our study has the limitation of being a retrospective study 
with limited patient size and no control group in a single 
medical center. This study is limited to infants who developed 
symptoms after birth and had a blood culture, although there 
could be an asymptomatic infection that could present later on 
in life or at another healthcare facility. However, this is one of 
the few clinical studies in pediatric patients in a predominantly 
Hispanic population in the United States. Our study was not 
designed to determine if there were any complications in our 
patients after their discharge. Specifically, no documented 
follow-up for meningitis was assessed in our study. At this point, 
there is no clear evidence of any of the adult complications of 
S. bovis infection for those patients with S. bovis bacteremia as 
newborns. Further studies need to be designed to determine 
if a neonatal infection will increase the risk of colon cancer as 
adults.
In conclusion, S. bovis bacteremia may be associated with gas-
trointestinal sepsis with respiratory distress as the most common 
symptom. In any patient with unexplained S. bovis bacteremia, 
clinicians should be aware of the possibility substantial morbidity 
and mortality and treat with antibiotics when appropriate.
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